Trials / Unknown
UnknownNCT02862158
Frequency Doubling Technology (FDT) Mobile Visual Field Testing
Evaluation of Different Frequency Doubling Technology (FDT) Mobile Devices for Visual Field Assessment
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single center, prospective study to evaluate the efficacy and reproducibility of frequency doubling technology (FDT)-based visual field devices compared to conventional Humphrey Visual Field (HVF) perimetry. The investigators plan to enroll 500 patients in this study.
Detailed description
Glaucoma is a leading cause of irreversible and preventable blindness world-wide. Insufficient evidence exists to support routine screening for glaucoma in a primary care setting due to the relatively low prevalence of the disease (Guirguis-Blake, 2005 and Moyer, 2013). Frequency doubling technology (FDT)-based perimetry is a relatively inexpensive and portable visual field testing device with a short testing time that has shown reasonable efficacy, sensitivity and specificity in screening for glaucoma in clinic- and community-based settings (Mansberger, 2005 and Nomoto 2009). The aim of our study is to compare the efficacy and reproducibility of FDT perimetry platforms compared with Humphrey Visual Field (HVF) perimetry (which is the gold clinical standard in clinics and hospitals) in detecting glaucomatous visual field defects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FDT visual field | |
| DEVICE | Standard HVF |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2022-11-01
- Completion
- 2022-11-01
- First posted
- 2016-08-10
- Last updated
- 2020-10-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02862158. Inclusion in this directory is not an endorsement.